213 related articles for article (PubMed ID: 2887615)
21. [Strong inhibition of gastric acid secretion: when is it justifiable?].
Dobrilla G; Amplaz S; Benvenuti S; Bertozzo A
G Clin Med; 1990; 71(8-9):521-6. PubMed ID: 1980653
[No Abstract] [Full Text] [Related]
22. Failure of histamine H2-receptor antagonist therapy in Zollinger-Ellison syndrome.
Stabile BE; Ippoliti AF; Walsh JH; Passaro E
Am J Surg; 1983 Jan; 145(1):17-23. PubMed ID: 6129812
[TBL] [Abstract][Full Text] [Related]
23. Effects of omeprazole on acid secretion and acid-related symptoms in patients with Zollinger-Ellison syndrome.
Bardram L; Stadil F
Scand J Gastroenterol Suppl; 1989; 166():95-100; discussion 111-3. PubMed ID: 2574912
[TBL] [Abstract][Full Text] [Related]
24. Uncertainties in the management of the Zollinger-Ellison Syndrome.
Malagelada JR
Gastroenterology; 1983 Jan; 84(1):188-9. PubMed ID: 6128287
[No Abstract] [Full Text] [Related]
25. Cimetidine-resistant Zollinger-Ellison syndrome: successful management with ranitidine.
Habal FM; Soldin SJ; Greenberg GR
Can Med Assoc J; 1983 Aug; 129(3):256-8. PubMed ID: 6305470
[TBL] [Abstract][Full Text] [Related]
26. [Interest of ranitidine, a new H2 receptor antagonist in the treatment of Zollinger-Ellison syndrome (author's transl)].
Mignon M; Vallot T; Mayeur S; Treffot MJ; Bonfils S
Gastroenterol Clin Biol; 1981 Jan; 5(1):42-7. PubMed ID: 6110608
[No Abstract] [Full Text] [Related]
27. Evaluation of antisecretory drug therapy of Zollinger-Ellison syndrome (ZES) using 24-hour pH monitoring.
Vallot T; Mignon M; Mazure R; Bonfils S
Dig Dis Sci; 1983 Jul; 28(7):577-84. PubMed ID: 6305607
[TBL] [Abstract][Full Text] [Related]
28. Medical management of patients with Zollinger-Ellison syndrome who have had previous gastric surgery: a prospective study.
Maton PN; Frucht H; Vinayek R; Wank SA; Gardner JD; Jensen RT
Gastroenterology; 1988 Feb; 94(2):294-9. PubMed ID: 3335308
[TBL] [Abstract][Full Text] [Related]
29. Use of ranitidine in the medical treatment of Zollinger-Ellison syndrome.
Bonfils S; Mignon M; Vallot ; Mayeur S
Scand J Gastroenterol Suppl; 1981 Jun; 69():119-23. PubMed ID: 6119775
[No Abstract] [Full Text] [Related]
30. [Histamine H-2 receptor antagonists and medical treatment of Zollinger-Ellison syndrome].
Bonfils S; Mignon M; Kloeti G
Sem Hop; 1978 Mar; 54(5-8):309-12. PubMed ID: 29338
[TBL] [Abstract][Full Text] [Related]
31. Cimetidine pharmacokinetics in patients with Zollinger-Ellison syndrome.
McArthur KE; Raufman JP; Seaman JJ; Ziemniak JA; Gardner JD; Jensen RT
Gastroenterology; 1987 Jul; 93(1):69-76. PubMed ID: 3582917
[TBL] [Abstract][Full Text] [Related]
32. Famotidine. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in peptic ulcer disease and other allied diseases.
Langtry HD; Grant SM; Goa KL
Drugs; 1989 Oct; 38(4):551-90. PubMed ID: 2573505
[TBL] [Abstract][Full Text] [Related]
33. [Famotidine versus ranitidine in the acute treatment of duodenal ulcer. A multicenter comparative study in Germany].
Simon B; Dammann HG; Jakob G; Miederer SE; Müller P; Ottenjann R; Paul F; Scholten T; Schütz E; Seifert E
Z Gastroenterol; 1985 Feb; 23(2):47-51. PubMed ID: 2865859
[TBL] [Abstract][Full Text] [Related]
34. Use of omeprazole in Zollinger-Ellison syndrome: a prospective nine-year study of efficacy and safety.
Metz DC; Strader DB; Orbuch M; Koviack PD; Feigenbaum KM; Jensen RT
Aliment Pharmacol Ther; 1993 Dec; 7(6):597-610. PubMed ID: 8161665
[TBL] [Abstract][Full Text] [Related]
35. Double blind comparison of the effects of cimetidine, ranitidine, famotidine, and placebo on intragastric acidity in 30 normal volunteers.
Merki HS; Witzel L; Walt RP; Neumann J; Scheurle E; Mappes A; Krammisch H; Heim J; Kaufmann D; Roehmel J
Gut; 1988 Jan; 29(1):81-4. PubMed ID: 2893761
[TBL] [Abstract][Full Text] [Related]
36. Clinical evaluation of the effect of omeprazole, cimetidine, famotidine and ranitidine on histamine induced cutaneous wheal and flare response.
Saha N; Sachdev A; Bhasin DK; Sankaranahyanan A; Khosla PP; Singh K; Sharma PL
Int J Clin Pharmacol Ther Toxicol; 1993 Jul; 31(7):322-5. PubMed ID: 8103763
[TBL] [Abstract][Full Text] [Related]
37. [Efficacy of combined anti-secretory treatment (cimétidine and pirenzepin) in Zollinger-Ellison syndrome].
Bonfils S; Mignon M; Danne O; Maria J
Nouv Presse Med; 1977 Nov; 6(38):3544-5. PubMed ID: 23518
[No Abstract] [Full Text] [Related]
38. Famotidine in the treatment of gastric and duodenal ulceration: overview of clinical experience.
Bianchi Porro G
Digestion; 1985; 32 Suppl 1():62-9. PubMed ID: 2866137
[TBL] [Abstract][Full Text] [Related]
39. Control of metastatic Zollinger-Ellison syndrome with high-dose H2-receptor antagonists.
Johnston SR; Wright PL
Br J Clin Pract; 1990 Dec; 44(12):792-3. PubMed ID: 2102253
[No Abstract] [Full Text] [Related]
40. The current status of the surgical and medical treatment of the Zollinger-Ellison syndrome.
Howard TJ; Passaro E
Surg Annu; 1990; 22():93-106. PubMed ID: 2408174
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
